A CRO’s guide to clinical supply chain success

Louise Oliver, Ph.D., CRO Strategic Operations Manager at Almac Clinical Services

Drug development has been subject to significant geopolitical change over recent years, with CROs bearing much of the burden.

Funding is now more constrained, budgets are taking longer to secure approval, and costs are being more closely scrutinised, as sponsors seek to ensure value. 

Against this high-pressure clinical research environment, even minor clinical supply chain disruption has the potential to impact outcomes and send costs spiralling for sponsors (and indirectly for the CROs operating trials on their behalf).

And while a single day’s delay can cost more than $600,000 in unrealised prescription drug sales, in addition to increased trial costs, it isn’t just profit margins that take a hit when trial operations veer off track. Delays that result in missed milestones and negative patient impact can hurt CROs’ reputations and relationships within the wider industry.

For CROs, avoiding clinical supply chain delays and disruption means putting proven measures in place to ensure the right drugs get to the right patients at the right time and temperature.

Achieving this starts with overcoming logistics barriers, striking the right balance with tech, breaking down silos, and picking a trusted CDMO partner capable of driving success with care and precision.

Lock in logistics early

Management of clinical supplies is a mission critical component of successful study delivery.  Yet it’s also commonly overlooked, with clinical packaging, labelling, and distribution often considered towards the end of trial set-up timelines.

This can leave CRO teams scrambling against the clock to ensure patients receive timely drug access and milestones are hit on time and on budget.

For many CROs, compressed timelines, frequent protocol amendments, and global regulatory complexity are significant hurdles that compound this challenge.

Locking in logistics at the earliest opportunity and having access to an extensive global depot network that accelerates distribution forms a key part of the solution. As does working with dedicated project managers who can anticipate risks before they impact timelines, interpret data, make sound judgment calls, and maintain productive relationships with all key stakeholders.

Strike the right balance with tech

In this AI age, it’s important to remember that clinical supply chain management remains a service-based business and human relationships are intrinsic to success.

Striking the right balance between technology-driven efficiency and personal attention delivers the best results.

This means: 

• Investing in the people and partnerships capable of effectively interpreting complex data and making appropriate judgement calls.
• Embracing automation for speed but not at the expense of human expertise.
• Selecting partners that take the time to know and understand CROs, their cultures, their priorities, and their challenges.

Break down the silos

Collaboration is what separates a good clinical supply chain from a great one. When silos and communication barriers exist, it’s easier for risk and potential issues to remain unnoticed.

As trials and protocols grow in scale and complexity, information-sharing becomes even more critical, making process standardisation to ensure consistency and relationship governance key priorities.

For CROs, this means seeking out CDMOs that offer partnership grounded in open and honest communication, and work at all levels across the entire CRO structure to assure complete alignment.

The best CDMO partners embed this into their governance model from the outset, ensuring teams develop a mutual understanding of one another’s processes, roles, and responsibilities.

But breaking down silos isn’t just a structural challenge; it’s a cultural one. Our Supply with Care philosophy keeps human relationships and patient care at the centre of everything, driving teams to deliver personalised service that goes well beyond contractual obligations.

Pick a partner that drives excellence

In a high-pressure clinical research environment, the right CDMO partner can be the difference between a trial that delivers and one that doesn’t.

When evaluating potential partners, look for:

• A genuine understanding of the CRO landscape: its culture, pressures, and what it takes to deliver. This deep understanding surpasses a transactional vendor relationship to drive real clinical supply chain success.
• Deep expertise across GCP, GMP, and CRO operations, with teams who have spent their careers focused specifically on this space, not just as supply chain professionals, but as people who understand how CROs think and operate.
• Personalised service as standard. The best partners assign dedicated operational leads who bring both supply chain expertise and genuine cultural alignment.
• A performance culture built on open communication, mutual respect, and continuous improvement. Robust KPIs, empowered project teams, and a commitment to joint problem-solving are the hallmarks of a CDMO that will help you deliver trials on time, on budget, and with confidence.

Ready to supercharge your clinical supply chain?

Clinical supply chain excellence requires early logistics planning, the right balance of technology and human expertise, a culture of open collaboration, and a CDMO partner that understands your world and is invested in your success.

For CROs navigating an increasingly complex and cost-sensitive environment, getting these foundations right is what keeps trials on track and reputations intact.

Discover more about Almac Clinical Services’ CRO solutions